Katherine Bryant

Learn More
The role of estrogen in the development of breast cancer is well recognized, and the use of selective estrogen receptor modulators (SERMs) to reduce breast cancer risk continues to be evaluated. Tamoxifen is the only SERM approved for the reduction of breast cancer incidence in women at high risk. This approval was based on results from the Breast Cancer(More)
Instagram is the fastest growing social network site globally. This study investigates motives for its use, and its relationship to contextual age and narcissism. A survey of 239 college students revealed that the main reasons for Instagram use are “Surveillance/Knowledge about others,” “Documentation,” “Coolness,” and “Creativity.” The next significant(More)
This article examines variables that predicted outpatient treatment entry within 6 months of residential detoxification. Patient data were collected from 632 injection drug users enrolled in a randomized trial conducted at eight detoxification programs within the National Drug Abuse Treatment Clinical Trials Network (CTN) with follow-up assessments(More)
With the advent of the Internet and social media, relationships and relationship formation have significantly changed. This is especially true in terms of finding romantic partners or “hook up” partners. The following study examined motives for using online dating websites and mobile dating applications, as well as attitudes toward those platforms, and(More)
In Georgia, most individuals reported with West Nile virus (WNV) disease have been diagnosed with West Nile neuroinvasive disease (WNND). Relatively few cases of West Nile Fever (WNF) are reported, and the burden of illness due to WNV is likely underestimated. From July through October 2003, WNV serologic testing was performed on enrolled patients>or=18(More)
Cetuximab, in combination with platinum chemotherapy plus 5-fluoruracil (5-FU), is approved for the first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN). Cetuximab manufactured by ImClone (US commercial cetuximab) potentially results in higher systemic exposures than cetuximab manufactured by Boehringer Ingelheim(More)
  • 1